Lexicon Pharmaceuticals to Report First Quarter 2026 Financial Results on May 7, 2026

Rhea-AI Summary

Lexicon Pharmaceuticals (Nasdaq: LXRX) will report first quarter 2026 financial results on May 7, 2026 before the market opens. Management will host a conference call and live webcast at 8:30 a.m. ET (7:30 a.m. CT) to discuss results and provide a business update.

Access the live webcast via the company Events page and use the dial-in to ask questions; an archived webcast will be posted after the call.

News Market Reaction – LXRX

+3.87%

4 alerts

+3.87% Session close to close

$690.18M Market Cap

0.1x Rel. Volume

In the Apr 30 session, LXRX gained 3.87%, reflecting a moderate positive market reaction. Our momentum scanner triggered 4 alerts that day, indicating moderate trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement schedules Lexicon’s Q1 2026 results for May 7, 2026 before market open, with an 8:...

Analysis

This announcement schedules Lexicon’s Q1 2026 results for May 7, 2026 before market open, with an 8:30 a.m. ET call and webcast. A prior ‘earnings date’ notice in February 2026 drew little price reaction, suggesting investors focus more on the underlying numbers and pipeline commentary. Key context includes earlier disclosures of 2025 revenues, narrowed losses, and active programs in heart failure, neuropathic pain and obesity.

Key Figures

Earnings release date: May 7, 2026 Conference call time ET: 8:30 a.m. ET Conference call time CT: 7:30 a.m. CT +2 more

5 metrics

Earnings release date May 7, 2026 First quarter 2026 financial results release before market open

Conference call time ET 8:30 a.m. ET Management call to discuss Q1 2026 results and business update

Conference call time CT 7:30 a.m. CT Central time for Q1 2026 results conference call

Dial-in phone number 800-715-9871 Participant access line for Q1 2026 conference call

Conference passcode 9826247 Passcode required for phone participants to join Q1 2026 call

Previous Earnings date Reports

1 past event · Latest: Feb 26 (Neutral)

Same Type Pattern 1 events

Date	Event	Sentiment	24h Move	Catalyst
Feb 26	Earnings date notice	Neutral	+0.0%	Announced timing and 8:30 a.m. ET call for Q4 2025 results.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Prior ‘earnings date’ scheduling news saw a 0% next-day move, suggesting limited typical reaction to timing announcements alone.

Recent Company History

This announcement sets the timing for Lexicon’s Q1 2026 results, similar to the prior notice on Feb 26, 2026 scheduling the Q4 2025 release and call. That earlier ‘earnings date’ headline produced a 0% 24-hour move, while the subsequent Q4 2025 earnings report on Mar 5, 2026 saw only a modest reaction. Against this backdrop, the current price decline of 6.63% precedes the actual financial disclosure and business update on May 7, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

THE WOODLANDS, Texas, April 30, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced the Company will release its first quarter 2026 financial results on Thursday, May 7, 2026, prior to market open. Management will conduct a conference call and live webcast at 8:30 a.m. ET (7:30 a.m. CT) that day to discuss the financial results and to provide a business update. 

Participants can access the conference call live via webcast on the Events page of the Company’s website at https://investors.lexpharma.com/. Participants who wish to ask a question may join by phone at 800-715-9871 and use passcode 9826247. An archived version of the webcast will be available on the Lexicon website.  

About Lexicon Pharmaceuticals  
Lexicon is a biopharmaceutical company with a mission of pioneering medicines that transform patients’ lives. Lexicon has a pipeline of drug candidates in discovery, preclinical, and clinical development in neuropathic pain, hypertrophic cardiomyopathy (HCM), obesity and metabolic disorders, and other cardiometabolic indications. For additional information, please visit www.lexpharma.com.   

For Investor and Media Inquiries:  
Lisa DeFrancesco   
Lexicon Pharmaceuticals, Inc.  
lexinvest@lexpharma.com  

FAQ

When will Lexicon Pharmaceuticals (LXRX) report its Q1 2026 financial results?

Lexicon will report Q1 2026 financial results on May 7, 2026 before market open at 8:30 a.m. ET. According to Lexicon, management will discuss the results on a conference call and live webcast and will provide a business update during the event.

How can investors access the Lexicon (LXRX) Q1 2026 webcast on May 7, 2026?

Investors can access the live webcast via the Events page on the company website at the scheduled time. According to Lexicon, the webcast will be available live and an archived version will be posted on the Lexicon investor website after the call.

How can participants ask questions during Lexicon (LXRX) Q1 2026 conference call?

Participants wishing to ask questions may join the conference call by phone and submit live questions during the Q&A portion. According to Lexicon, callers should dial the provided number and use the published passcode to be admitted and ask questions.

What dial-in and passcode should I use for the Lexicon (LXRX) May 7, 2026 call?

Use the dial-in number 800-715-9871 and enter passcode 9826247 to join the call by phone. According to Lexicon, these details grant access for participants who wish to listen and ask questions during the scheduled conference call.

Will the Lexicon (LXRX) May 7, 2026 webcast be available after the live event?

Yes, an archived version of the webcast will be available on the company's investor website after the live call concludes. According to Lexicon, investors can replay the archived webcast on the Events page for later review.